Showing results (1661-1670 of 30,483) with videos related to
Sort By:
Pageof 3,049
Frontiers in Pharmacology|January 26, 2023
Activity of the genus Zanthoxylum against diseases caused by protozoa: A systematic reviewJuliana Correa-Barbosa, Daniele Ferreira Sodré, Pedro Henrique Costa Nascimento, et al.Frontiers in Pharmacology|January 26, 2023
Research progress of treatment of functional dyspepsia with traditional Chinese medicine compound based on cell signal pathwayYujiao Song, Defei Yin, Zhenyi Zhang, et al.Frontiers in Pharmacology|January 26, 2023
Advancements in lead therapeutic phytochemicals polycystic ovary syndrome: A reviewEr-Dan Luo, Hai-Mei Jiang, Wei Chen, et al.Frontiers in Pharmacology|January 26, 2023
Mapping knowledge landscapes and emerging trends of sonodynamic therapy: A bibliometric and visualized studyZhenjiang Wu, Kunming Cheng, Zefeng Shen, et al.Frontiers in Pharmacology|January 26, 2023
Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosisHaoyue Zhang, Yuying He, Lina Davies Forsman, et al.Frontiers in Pharmacology|January 26, 2023
Acetylsalicylic acid reduces cigarette smoke withdrawal-induced anxiety in rats via modulating the expression of NFĸB, GLT-1, and xCTAlaa M Hammad, Lujain F Alzaghari, Malek Alfaraj, et al.Frontiers in Pharmacology|January 26, 2023
Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting systemXue-Feng Jiao, Kunpeng Song, Xueyan Jiao, et al.Frontiers in Pharmacology|January 26, 2023
Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and managementTommaso Mazzierli, Federica Allegretta, Enrico Maffini, et al.Frontiers in Pharmacology|January 26, 2023
Pharmacological activities and mechanisms of action of hypophyllanthin: A reviewWan Azmira Wan Saidin, Ibrahim Jantan, Siti Mariam Abdul Wahab, et al.Frontiers in Pharmacology|January 26, 2023
Discovery of a potent olaparib-chlorambucil hybrid inhibitor of PARP1 for the treatment of cancerHongyu Qin, Jian Zhang, Yilu Zhao, et al.Pageof 3,049